Evidence map›Paper›PMID 36748435›Full record

ArticleMicrobial genomics2023

Multiplex MinION sequencing suggests enteric adenovirus F41 genetic diversity comparable to pre-COVID-19 era.

Mailis Maes, Fahad Khokhar, Sam A J Wilkinson, Andrew D Smith, Ganna Kovalenko, Gordon Dougan, Joshua Quick, Nicholas J Loman, Stephen Baker, Martin D Curran and 2 more

Open access · goldAbstract read
In one paragraph

Article in Microbial genomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Mailis MaesClinical Microbiology and Public Health Laboratory, UK Health Security Agency, Addenbrooke's Hospital, Cambridge, UK.
Fahad KhokharCambridge Institute of Therapeutic Immunology and Infectious Disease, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK.
Sam A J WilkinsonInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham, UK.
Andrew D SmithInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham, UK.
Ganna KovalenkoDivision of Virology, Department of Pathology, University of Cambridge, Cambridge, UK.
Gordon DouganCambridge Institute of Therapeutic Immunology and Infectious Disease, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK.
Joshua QuickInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham, UK.
Nicholas J LomanInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham, UK.
Stephen BakerCambridge Institute of Therapeutic Immunology and Infectious Disease, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK.
Martin D CurranCambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Jordan P SkittrallClinical Microbiology and Public Health Laboratory, UK Health Security Agency, Addenbrooke's Hospital, Cambridge, UK.
Charlotte J HouldcroftDepartment of Genetics, University of Cambridge, Cambridge, UK.
University of Cambridge · GBUniversity of Birmingham · GBAddenbrooke's Hospital · GBCambridge University Hospitals NHS Foundation Trust · GB

Funding

Department of HealthMedical Research Council MR/S035362/1Wellcome TrustWellcome Trust 206298/B/17/ZWellcome Trust 215515/Z/19/Z
6 · The paper itself

Abstract

Human adenovirus F41 causes acute gastroenteritis in children, and has recently been associated with an apparent increase in paediatric hepatitis of unknown aetiology in the UK, with further cases reported in multiple countries. Relatively little is known about the genetic diversity of adenovirus F41 in UK children; and it is unclear what, if any, impact the COVID-19 pandemic has had on viral diversity in the UK. Methods that allow F41 to be sequenced from clinical samples without the need for viral culture are required to provide the genomic data to address these questions. Therefore, we evaluated an overlapping-amplicon method of sequencing adenovirus genomes from clinical samples using Oxford Nanopore technology. We applied this method to a small sample of adenovirus-species-F-positive extracts collected as part of standard care in the East of England region in January-May 2022. This method produced genomes with >75 % coverage in 13/22 samples and >50 % coverage in 19/22 samples. We identified two F41 lineages present in paediatric patients in the East of England in 2022. Where F41 genomes from paediatric hepatitis cases were available (

Indexed as

Adenoviridae InfectionsCOVID-19AdenoviridaeChildGenetic VariationHumansPandemicsSequence AnalysisadenovirusDNA virusgenetic epidemiologygenomicshepatitisvirology

Identifiers

PMID36748435
PMCPMC9973849
OpenAlexW4313641545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.